Chester County News and Community Website
PHILADELPHIA, PA — Latus Bio added veteran biopharmaceutical executives Donald Hayden and Michael MacLean to its board as the Philadelphia biotechnology company moves into clinical development with gene therapies targeting …
Latus Bio Adds Biotech Veterans as Gene Therapies Enter Clinic Read More PHILADELPHIA, PA — Latus Bio has appointed biotechnology executive Bethany Mancilla as chief business officer, bringing in a veteran corporate development leader as the gene therapy company prepares to advance …
Latus Bio Adds Dealmaking Veteran as Clinical Push Nears Read More PHILADELPHIA, PA — Latus Bio said it will present new preclinical and computational data related to experimental gene therapies for Huntington’s disease and CLN2 disease at the ASGCT 2026 Annual …
Latus Bio to Present Gene Therapy Data at ASGCT Read More PHILADELPHIA, PA — Latus Bio, Inc. unveiled a significant expansion of its artificial intelligence and machine learning program as the company pushes deeper into AI-driven AAV capsid and payload design. …
Biotech Breakthrough: Latus Bio Doubles Down on AI to Revolutionize Gene Therapy Read More PHILADELPHIA, PA — Latus Bio, Inc. has announced a significant advancement in the field of gene therapy with the publication of its latest research in Nature Communications. The study, led …
Latus Bio Unveils Breakthrough in Gene Therapy for Neurodegenerative Diseases Read More PHILADELPHIA, PA — Latus Bio, Inc. has unveiled groundbreaking research on a novel adeno-associated virus (AAV) capsid variant, AAV-Ep+, which shows significant promise for advancing gene therapy applications. Published in …
Latus Bio Announces Breakthrough in Gene Therapy with AAV-Ep+ Capsid Read More PHILADELPHIA, PA — Latus Bio Inc. (Latus) will showcase its groundbreaking progress in AAV capsid variants—AAV-DB-3 and AAV-Ep+—at the 2025 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting …
Latus Bio to Spotlight Advances in Gene Therapy at ASGCT Annual Meeting Read More